Please Wait.....
Report
United States Alzheimer'S Disease Therapeutics & Diagnostics Market Forecast 2022-2028
Market Report I 2022-06-21 I 150 Pages I Inkwood Research
KEY FINDINGS
The United States Alzheimer's disease therapeutics & diagnostics market is estimated to progress with a 6.62% CAGR during the forecasting years 2022-2028. The market growth is driven by regular cognitive assessments of senior citizens and the easy availability of relevant drugs.
MARKET INSIGHTS
Alzheimer's is a degenerative disorder that attacks the neurons, affecting thinking, memory loss, behavioral changes, and language skills. The market is anticipated to grow, driven by the vast number of last-stage pipeline and disease-modifying drugs. The United States is the largest player in Alzheimer's disease diagnostics and therapeutics market. Besides, the country also has high expenditure on disease management and high detection rates in primary care settings. According to the US Census Bureau, the population of Americans aged 65+ is expected to surge to 88 million by 2050. These factors are expected to drive the market growth during the forecast years.
Furthermore, the United States Food and Drug Administration has approved various molecules to treat Alzheimer's disease. Also, a combination drug containing Memantine and Donepezil is widely available in the market. The availability of various drugs and molecules to cure the disease produces lucrative opportunities for medicine manufacturers.
COMPETITIVE INSIGHTS
Leading players in the market include GE Healthcare, Baxter International Inc, Amarantus Bioscience Holdings Inc, Cognoptix Inc, Merck & Co Inc, etc.
Our report offerings include:
- Explore key findings of the overall market
- Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
- Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
- Market Segmentation caters to a thorough assessment of key segments with their market estimations
- Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
- Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
- Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
- Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. COUNTRY SNAPSHOT
2.3. COUNTRY ANALYSIS
2.4. KEY GROWTH ENABLERS
2.5. KEY CHALLENGES
3. KEY ANALYTICS
3.1. PARENT MARKET ANALYSIS
3.2. TIMELINE OF ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET
3.3. PHASES AND STERNNESS OF ALZHEIMER'S DISEASE
3.4. IMPACT OF COVID-19 ON ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET
3.5. KEY MARKET TRENDS
3.6. PORTER'S FIVE FORCES ANALYSIS
3.6.1. BUYERS POWER
3.6.2. SUPPLIERS POWER
3.6.3. SUBSTITUTION
3.6.4. NEW ENTRANTS
3.6.5. INDUSTRY RIVALRY
3.7. KEY BUYING CRITERIA
3.8. SUPPLY CHAIN ANALYSIS
3.9. OPPORTUNITY MATRIX
3.10. PESTLE ANALYSIS - UNITED STATES
4. MARKET BY THERAPEUTICS & DIAGNOSTICS
4.1. THERAPEUTICS
4.1.1. DRUGS
4.1.1.1. MARKETED DRUGS
4.1.1.2. PIPELINE DRUGS
4.1.2. DISEASE STAGE
4.1.2.1. LATE-STAGE: SEVERE AD
4.1.2.2. EARLY/MIDDLE STAGE: MILD TO MODERATE AD
4.1.2.3. PRODROMAL STAGE
4.1.3. GENERIC & BRANDED
4.1.3.1. BRANDED
4.1.3.2. GENERIC
4.2. DIAGNOSTICS
4.2.1. LUMBAR PUNCTURE TEST
4.2.2. POSITRON EMISSION TOMOGRAPHY
4.2.3. ELECTROENCEPHALOGRAPHY
4.2.4. MAGNETIC RESONANCE IMAGING
4.2.5. COMPUTED TOMOGRAPHY
4.2.6. BLOOD TEST
4.2.7. OTHER DIAGNOSTICS
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIC DEVELOPMENTS
5.1.1. MERGERS & ACQUISITIONS
5.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
5.1.3. PARTNERSHIPS & AGREEMENTS
5.1.4. BUSINESS EXPANSIONS, ANNOUNCEMENTS, & DIVESTITURES
5.2. COMPANY PROFILES
5.2.1. AMARANTUS BIOSCIENCE HOLDINGS INC
5.2.2. BAXTER INTERNATIONAL INC
5.2.3. BIOGEN INC
5.2.4. COGNOPTIX INC
5.2.5. ELI LILLY & COMPANY
5.2.6. GE HEALTHCARE
5.2.7. JOHNSON & JOHNSON
5.2.8. MERCK & CO INC
5.2.9. PFIZER INC
LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS
TABLE 2: UNITED STATES ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, BY THERAPEUTICS & DIAGNOSTICS, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 3: UNITED STATES ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, BY THERAPEUTICS & DIAGNOSTICS, FORECAST YEARS, 2022-2028 (IN $ MILLION)
TABLE 4: UNITED STATES ALZHEIMER'S DISEASE THERAPEUTICS MARKET, BY DRUGS, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 5: UNITED STATES ALZHEIMER'S DISEASE THERAPEUTICS MARKET, BY DRUGS, FORECAST YEARS, 2022-2028 (IN $ MILLION)
TABLE 6: UNITED STATES ALZHEIMER'S DISEASE THERAPEUTICS MARKET, BY DISEASE STAGE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 7: UNITED STATES ALZHEIMER'S DISEASE THERAPEUTICS MARKET, BY DISEASE STAGE, FORECAST YEARS, 2022-2028 (IN $ MILLION)
TABLE 8: UNITED STATES ALZHEIMER'S DISEASE THERAPEUTICS MARKET, BY GENERIC & BRANDED, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 9: UNITED STATES ALZHEIMER'S DISEASE THERAPEUTICS MARKET, BY GENERIC & BRANDED, FORECAST YEARS, 2022-2028 (IN $ MILLION)
TABLE 10: UNITED STATES ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, BY DIAGNOSTICS, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 11: UNITED STATES ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, BY DIAGNOSTICS, FORECAST YEARS, 2022-2028 (IN $ MILLION)
TABLE 12: LIST OF MERGERS & ACQUISITIONS
TABLE 13: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 14: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 15: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, & DIVESTITURES
LIST OF FIGURES
FIGURE 1: PIPELINE DRUGS RELATED TO ALZHEIMER'S DISEASE
FIGURE 2: KEY MARKET TRENDS
FIGURE 3: PORTER'S FIVE FORCES ANALYSIS
FIGURE 4: KEY BUYING CRITERIA
FIGURE 5: SUPPLY CHAIN ANALYSIS
FIGURE 6: OPPORTUNITY MATRIX
FIGURE 7: PESTLE ANALYSIS - UNITED STATES
FIGURE 8: UNITED STATES ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, GROWTH POTENTIAL, BY THERAPEUTICS & DIAGNOSTICS, IN 2021
FIGURE 9: UNITED STATES ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, BY THERAPEUTICS, 2022-2028 (IN $ MILLION)
FIGURE 10: UNITED STATES ALZHEIMER'S DISEASE THERAPEUTICS MARKET, GROWTH POTENTIAL, BY DRUGS, IN 2021
FIGURE 11: UNITED STATES ALZHEIMER'S DISEASE THERAPEUTICS MARKET, BY MARKETED DRUGS, 2022-2028 (IN $ MILLION)
FIGURE 12: UNITED STATES ALZHEIMER'S DISEASE THERAPEUTICS MARKET, BY PIPELINE DRUGS, 2022-2028 (IN $ MILLION)
FIGURE 13: UNITED STATES ALZHEIMER'S DISEASE THERAPEUTICS MARKET, GROWTH POTENTIAL, BY DISEASE STAGE, IN 2021
FIGURE 14: UNITED STATES ALZHEIMER'S DISEASE THERAPEUTICS MARKET, BY LATE-STAGE: SEVERE AD, 2022-2028 (IN $ MILLION)
FIGURE 15: UNITED STATES ALZHEIMER'S DISEASE THERAPEUTICS MARKET, BY EARLY/MIDDLE STAGE: MILD TO MODERATE AD, 2022-2028 (IN $ MILLION)
FIGURE 16: UNITED STATES ALZHEIMER'S DISEASE THERAPEUTICS MARKET, BY PRODROMAL STAGE, 2022-2028 (IN $ MILLION)
FIGURE 17: UNITED STATES ALZHEIMER'S DISEASE THERAPEUTICS MARKET, GROWTH POTENTIAL, BY GENERIC & BRANDED, IN 2021
FIGURE 18: UNITED STATES ALZHEIMER'S DISEASE THERAPEUTICS MARKET, BY BRANDED, 2022-2028 (IN $ MILLION)
FIGURE 19: UNITED STATES ALZHEIMER'S DISEASE THERAPEUTICS MARKET, BY GENERIC, 2022-2028 (IN $ MILLION)
FIGURE 20: UNITED STATES ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, BY DIAGNOSTICS, 2022-2028 (IN $ MILLION)
FIGURE 21: UNITED STATES ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, GROWTH POTENTIAL, BY DIAGNOSTICS, IN 2021
FIGURE 22: UNITED STATES ALZHEIMER'S DISEASE DIAGNOSTICS MARKET, BY LUMBAR PUNCTURE TEST, 2022-2028 (IN $ MILLION)
FIGURE 23: UNITED STATES ALZHEIMER'S DISEASE DIAGNOSTICS MARKET, BY POSITRON EMISSION TOMOGRAPHY, 2022-2028 (IN $ MILLION)
FIGURE 24: UNITED STATES ALZHEIMER'S DISEASE DIAGNOSTICS MARKET, BY ELECTROENCEPHALOGRAPHY, 2022-2028 (IN $ MILLION)
FIGURE 25: UNITED STATES ALZHEIMER'S DISEASE DIAGNOSTICS MARKET, BY MAGNETIC RESONANCE IMAGING, 2022-2028 (IN $ MILLION)
FIGURE 26: UNITED STATES ALZHEIMER'S DISEASE DIAGNOSTICS MARKET, BY COMPUTED TOMOGRAPHY, 2022-2028 (IN $ MILLION)
FIGURE 27: UNITED STATES ALZHEIMER'S DISEASE DIAGNOSTICS MARKET, BY BLOOD TEST, 2022-2028 (IN $ MILLION)
FIGURE 28: UNITED STATES ALZHEIMER'S DISEASE DIAGNOSTICS MARKET, BY OTHER DIAGNOSTICS, 2022-2028 (IN $ MILLION)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security